Pharmacogenetic aspects of drug interactions in stroke patients (using the CYP2C9 gene as an example)
Relevance. The safety of stroke pharmacotherapy against the background of polypharmacy is of paramount importance in modern clinical practice. Genetic polymorphisms of cytochrome P450 genes, including the CYP2C9 gene, significantly contribute to drug responses and drug-drug interactions. The alleles with reduced fun...